RxDoctor Payments Data

James McCoy, APRN

Family · Knoxville, TNNPI 1063426286

Payments from drug & device makers

$2,361in general payments, 2019–2025

Across 26 payments — averaging $90.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Relievant Medsystems, Inc.$1K
  • Medtronic$857
  • Collegium Pharmaceutical, Inc.$115
  • GRT US Holding, Inc.$44
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$34
  • Boston Scientific$28
  • plus $48 from 2 others

What the payments were for

  • Travel & lodging$1,58267%
  • Food & beverage$73431%
  • Education$452%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,361 in reported general payments places this provider in the 80th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$90,715
Medicare patients
374
Services billed
832

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate24$15,459
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen469$13,924
Buprenorphine45$11,761
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen450$11,074
Morphine Sulfate ErMorphine Sulfate150$5,119
Fentanyl38$3,964
Gabapentin254$3,032
Naloxone Hcl45$2,971
Morphine Sulfate74$2,133
Oxycodone Hcl103$1,522
Pregabalin96$1,215
Tramadol Hcl89$937
Baclofen39$466
Tizanidine Hcl43$363
Methadone Hcl15$341

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er$115$15,45924 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,706 family providers in Tennessee.

Other family in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →